Astrazeneca Regulatory News (AZN)

RESOLUTION

VOTES FOR

% OF VOTES CAST

VOTES AGAINST

% OF VOTES CAST

VOTES CAST IN TOTAL

TOTAL VOTES CAST AS A % OF ISSUED SHARE CAPITAL

VOTES WITHHELD

1

To receive the Company's Accounts and the Reports of the Directors and Auditor for the year ended 31 December 2014

877,576,463

99.67

2,921,581

0.33

880,498,044

69.68%

10,675,935

2

To confirm dividends

886,527,613

99.66

2,986,602

0.34

889,514,215

70.40%

1,659,763

3

To re-appoint KPMG LLP, London as Auditor

876,751,815

98.61

12,397,571

1.39

889,149,386

70.37%

2,024,593

4

To authorise the Directors to agree the remuneration of the Auditor

887,495,062

99.82

1,629,520

0.18

889,124,582

70.37%

2,049,398

5a

To re-elect Leif Johansson as a Director

851,461,560

95.76

37,705,142

4.24

889,166,702

70.37%

2,007,277

5b

To re-elect Pascal Soriot as a Director

888,590,119

99.95

426,241

0.05

889,016,360

70.36%

2,157,620

5c

To re-elect Marc Dunoyer as a Director

885,602,969

99.62

3,374,856

0.38

888,977,825

70.36%

2,196,155

5d

To elect Cori Bargmann as a Director

888,638,513

99.96

351,446

0.04

888,989,959

70.36%

2,184,021

5e

To re-elect Geneviève Berger as a Director

888,552,754

99.95

465,106

0.05

889,017,860

70.36%

2,156,120

5f

To re-elect Bruce Burlington as a Director

880,639,560

99.88

1,091,107

0.12

881,730,667

69.78%

9,443,312

5g

To re-elect Ann Cairns as a Director

888,587,093

99.95

465,731

0.05

889,052,824

70.36%

2,121,156

5h

To re-elect Graham Chipchase as a Director

876,994,757

99.46

4,732,631

0.54

881,727,388

69.78%

9,445,684

5i

To re-elect Jean-Philippe Courtois as a Director

880,585,784

99.87

1,137,760

0.13

881,723,544

69.78%

9,450,753

5j

To re-elect Rudy Markham as a Director

855,335,488

99.27

6,300,712

0.73

861,636,200

68.19%

29,537,348

5k

To re-elect Shriti Vadera as a Director

888,387,120

99.93

582,556

0.07

888,969,676

70.36%

2,204,192

5l

To re-elect Marcus Wallenberg as a Director

846,091,821

98.19

15,599,701

1.81

861,691,522

68.20%

29,482,025

6

To approve the Annual Report on Remuneration for the year ended 31 December 2014

739,049,685

84.11

139,601,566

15.89

878,651,251

69.54%

12,522,725

7

To authorise limited EU political donations

859,081,444

97.36

23,307,997

2.64

882,389,441

69.83%

8,784,535

8

To authorise the Directors to allot shares

808,454,239

91.14

78,551,101

8.86

887,005,340

70.20%

4,168,208

9

To authorise the Directors to disapply pre-emption rights

875,263,416

98.61

12,347,679

1.39

887,611,095

70.25%

3,562,455

10

To authorise the Company to purchase its own shares

876,130,644

98.54

13,023,264

1.46

889,153,908

70.37%

2,019,960

11

To reduce the notice period for general meetings

778,280,838

87.53

110,881,255

12.47

889,162,093

70.37%

2,011,885

12

To adopt new Articles of Association

886,456,629

99.90

900,552

0.10

887,357,181

70.23%

3,813,971